Koper voor klinische onderzoeksorganisatie in Europa

Bedrijf gevraagd

• Omvang: Middelgroot bedrijf
• Inkomsten: 2 - 20 M EUR
• Locatie van de doelonderneming: Europa.
• CFIE PHB273

Overview of buyer for Clinical Research organization in Europe

This technology-driven clinical research company is advancing precision medicine by facilitating patient access to investigational treatments, regardless of location. Through its integrated platform, the company connects physicians, research sites, and clinical trial sponsors worldwide, enabling efficient and meaningful patient matching for clinical trials and compassionate use programs. This approach is transforming the clinical development landscape by making studies readily accessible to treating physicians across various therapeutic areas.

Profile of buyer for Clinical Research organization in Europe

The company operates a comprehensive research. The platform serves as a bridge, uniting global clinical research resources and empowering treating physicians to match patients with relevant studies quickly. Its primary mission is to accelerate access to new treatments, especially in complex fields like oncology, infectious diseases, neurology, immunology, cardiology, and rare diseases, aiming to simplify and speed up clinical trials at reduced costs.

Activity and Products of buyer for Clinical Research organization in Europe

The company offers an innovative technology platform that provides comprehensive support for the clinical development process. It includes features such as a global sponsor and study registry, patient-matching technology, site and physician qualification, rapid study activation, and real-time data capture and evidence generation. This system enables direct access to key decision-makers at manufacturers, simplifies study feasibility and patient enrollment, and ensures seamless regulatory compliance. It is designed to streamline clinical trials, from study feasibility to data collection, providing an end-to-end solution for sponsors and research sites.

Highlights of buyer for Clinical Research organization in Europe

• Connects thousands of sponsors, research sites, and investigators, facilitating direct access for physicians to engage in clinical trials and compassionate use programs.
• Matches patients efficiently with relevant clinical trials based on study criteria, site capabilities, and patient clinical characteristics.
• Activates research sites within 5 working days using a standardized master contract and fee schedule, enabling quicker patient enrollment and access.
• Integrates data capture and evidence generation to support product development across various therapeutic indications.
• Provides just-in-time connections with key decision-makers, accelerating the availability of investigational products and new treatments for patients globally.

Meer informatie over: Koper voor klinische onderzoeksorganisatie in Europa

Neem gerust contact met ons op als u meer wilt weten over: Koper voor klinische onderzoeksorganisatie in Europa. Voor meer CRO-bedrijven te koop, bezoek CRO-bedrijven te koop. Voor andere CRO-kopers, bezoek CRO-bedrijven gevraagd. Als u in plaats daarvan geïnteresseerd bent in farmaceutische bedrijven te koop, bezoek farmaceutische bedrijven te koop . Voor farmaceutische kopers, bezoek farmaceutische bedrijven gevraagd.